Views Navigation

Event Views Navigation


4th International Conference on Multiple Myeloma

Centre Expo Congrès Mandelieu 806 Avenue de Cannes Mandelieu, La Napoule

Starts:  Oct 5, 2018 8:30 AM (CET) Ends:  Oct 7, 2018 1:00 PM (CET) 4th International Conference on MULTIPLE MYELOMA October 5-7, 2018 – Mandelieu, France  Chairs: Kenneth C. Anderson, Maria Victoria Mateos, Philippe Moreau  This meeting aims to bring to the forefront the latest data and information in the field of Multiple Myeloma, providing […]

60th American Society of Hematology (ASH) 2018

San Diego Convention Center 111 W Harbor Dr., San Diego, CA

Starts: Dec 8, 2018 7:00 AM (PT) Ends: Dec 12, 2018 1:00 PM (PT) The premier event in malignant and non-malignant hematology December 1-4, 2018 San Diego, CA See below for quick links to resources from the 2018 ASH Annual Meeting. Mark your calendar for the world’s most comprehensive hematology event of the year, the […]

2020 IMF Patient & Family Webinar: Multiple Myeloma – New Treatments, Diversity, and Caregiver Support

Join the IMF Patient & Family Webinar. This free two-hour webinar features a panel discussion about the latest treatments, diversity and caregiver support led by IMF Chief Medical Officer Dr. Joseph Mikhael of Translational Genomics Research Institute (TGen). IMF President, Founder, and CEO Susie Durie and IMF Vice President of Support Groups Robin Tuohy will lead a special segment dedicated to caregiver support.

Other panelists include Deepu Madduri, MD of Tisch Cancer Institute/Mount Sinai Hospital; Craig Emmitt Cole, MD of Michigan State University; and Beth Faiman PhD, MSN, APRN-BC, AOCN, FAAN of Cleveland Clinic Taussig Cancer Institute.

NYC-Miami Myeloma MRD 2020 Virtual Meeting


This meeting will bring together leading experts in multiple myeloma who will discuss the use of measurable residual disease (MRD) in clinical and trial settings, furthering our understanding of recent advances in the disease, and encouraging interactive discussions.

Eliminating Disparities in Relapsed/Refractory Multiple Myeloma Care


Despite expanding treatment options for relapsed/refractory multiple myeloma (MM), hematology/oncology teams face persistent barriers to the delivery of quality care across MM patient populations. Join our expert faculty for this live webinar as they share real-world insights and lessons learned from an MM quality initiative conducted within two large oncology health systems.

North America Educational Workshop – Now Virtual


The North America IMS Educational Workshop scheduled to occur in Miami, Florida will now be offered in a virtual format on November 6-7, 2020. While advance registration is required, access to the above IMS Educational Workshops will be made available on a complimentary basis for all IMS members. The registration rate for non-members will be […]

2nd Immune Effector Cell Therapy in Multiple Myeloma Workshop

Sheraton Boston Hotel 39 Dalton Street, Boston

Within a very short period of time, there has been a tremendous advance in development of cellular immunotherapies in multiple myeloma (MM). As we have observed during our event last year, a number of groups have presented their data on CAR T-cell therapy in MM. Although the studies are currently small in size, they are accruing patients very quickly, both in the United States and globally.

These developments have highlighted the need for a focused discussion about the state-of-the-art in immune and cellular therapies. With this in mind, the International Myeloma Society (IMS) is organizing the 2nd Immune Effector Cell Therapy in Multiple Myeloma Workshop. This two-day meeting will review CAR-T clinical data and promising preclinical leads, gain consensus on issues in management of toxicity, and discuss ongoing and future clinical trials. This year we are also including a session on T cell-engaging bispecific antibody-based approaches.